Metsera, Inc. MTSR
70.50 USD 0.00 (+0.00%)
At closeNov 13, 2025, 4:00 PM EST
70.13 Day range 70.76
52-week range unavailable
- YTD
- 0.00%
- 1 year
- 0.00%
News
proactiveinvestors.co.uk Railpen lifts IP Group offer with cash, Nanopore stake and Metsera upside Railpen has raised its takeover proposal for IP Group PLC (LSE:IPO), offering shareholders a mix of cash, shares in Oxford Nanopore and a contingent payout linked to the biotech firm Metsera. The…
proactiveinvestors.co.uk IP Group shares jump 9% as Metsera deal drives return to growth Shares in IP Group PLC (LSE:IPO) rose 9% to 53.5p on Monday after the company reported net asset value per share climbing to 110.4p, with total NAV reaching £975.1 million. The recovery was driven…
defenseworld.net Metsera Inc. (NASDAQ:MTSR) Given Average Recommendation of “Hold” by Brokerages Metsera Inc. (NASDAQ: MTSR - Get Free Report) has been given a consensus rating of "Hold" by the eight analysts that are presently covering the firm, Marketbeat Ratings reports. One investment…
benzinga.com Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market Paramount, Comcast, Netflix, Clearlake, Blackstone, and others drive major M&A activity. On the sell side are WBD, Bill.com and TuneIn.
benzinga.com Ozempic Maker Novo Nordisk Faces Board Shakeup Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesity drug market.
benzinga.com Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields 
businesswire.com Pfizer Completes Acquisition of Metsera NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biopharmaceutical company…
reuters.com Metsera shareholders vote for $10 billion acquisition by Pfizer Metsera shareholders on Thursday approved Pfizer's takeover offer worth up to $10 billion, allowing the U.S. pharmaceutical giant re-entry into the lucrative obesity treatment market after a fierce…
fool.com Why Metsera's Share Price Is Plummeting This Week Metsera was the target of a bidding war by pharma giants. The company has an innovative obesity drug candidate.
youtube.com Instacart Up on Earnings Beat; Metsera Down on Takeover Battle | Stock Movers On this episode of Stock Movers with Lisa Mateo: - Metsera (MTSR) shares tank in premarket trading after Novo Nordisk A/S declined to further raise its offer for the US maker of an experimental…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
proactiveinvestors.com Pfizer to acquire Metsera after winning bidding contest against Novo Nordisk Metsera (NASDAQ:MTSR) announced that it has entered into an amended merger agreement with Pfizer Inc (NYSE:PFE, ETR:PFE), under which Pfizer will acquire the biotech company for up to $86.25 per…
youtube.com Pfizer to buy Metsera in deal worth up to $10 billion Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping a fierce biotech bidding war between the New York-based pharma giant and Danish rival Novo Nordisk. Metsera accepted…
youtube.com Pfizer CEO: Metsera deal gives us 'one of the most exciting, advanced portfolios' in obesity drugs Pfizer CEO Albert Bourla joins Squawk on the Street to discuss the company's up to $10 billion acquisition of Metsera, the competitive landscape in obesity drugs, and Pfizer's strategy for clinical…
investopedia.com 5 Things to Know Before the Stock Market Opens Stock futures are surging this morning after U.S. lawmakers passed a key procedural hurdle as part of an agreement that could bring an end to the shutdown that has lasted nearly six weeks; President…
barrons.com Pfizer Is Buying Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Winner. The Danish drugmaker's shareholders appear relieved that it hasn't overpaid for largely unproven treatments.- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Monday.Com, Metsera, Profrac Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 1.5% on Monday.
benzinga.com Monday.Com, Metsera, Profrac Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com Why Viasat Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket 
wsj.com Novo Nordisk Shares Rise After Withdrawal from Metsera Takeover Battle Shares climbed as much as 3.5% in early European trade after Pfizer agreed to buy Metsera in a deal that could be worth more than $10 billion following a heated takeover battle.
reuters.com Novo Nordisk shares rise after dropping Metsera bid Shares in Novo Nordisk NOVOb.CO rose in early trade on Monday, after the Wegovy-maker on Saturday dropped its bid for U.S. weight loss drug company Metsera, ending a bidding war with rival Pfizer.
seekingalpha.com Wall Street Brunch: Here Come The 13Fs 13F filings this week will reveal hedge fund and institutional moves, offering insight into smart money positioning amid recent market highs. Earnings season is winding down, with 90% of S&P 500…
globenewswire.com Novo Nordisk will not increase its proposal to acquire Metsera, Inc. Bagsværd, Denmark, 8 November 2025 – Novo Nordisk today confirms that it does not intend to make an increased offer to acquire Metsera. On 30 October 2025, Novo Nordisk announced the submission of an…
wsj.com Pfizer has agreed to buy weight-loss drug startup Metsera in a deal that could be worth more than $10 billion, besting rival Novo Nordisk following a heated bidding war Pfizer prevails over rival Novo Nordisk after an unusual bidding war for the weight-loss startup.
prnewswire.com Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer Revised transaction values Metsera at up to $86.25 per share Metsera's Board of Directors unanimously recommends that Metsera stockholders approve the adoption of the amended Pfizer merger agreement…
reuters.com Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports Pfizer has submitted a sweetened bid for obesity drug developer Metsera , as its fight against rival Novo Nordisk escalates, Bloomberg News reported on Friday.
benzinga.com 10 Health Care Stocks Whale Activity In Today's Session - benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday 
benzinga.com Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com Gold Gains Over 1%; Quantum Computing Shares Plunge 
benzinga.com PROS Holdings, MBX Biosciences, Metsera, Anywhere Real Estate And Other Big Stocks Moving Higher On Monday - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why MBX Biosciences Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session 
benzinga.com ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com Methode Electronics, Ultragenyx Pharmaceutical And Other Big Stocks Moving Lower In Thursday's Pre-Market Session 
benzinga.com Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday 
benzinga.com Kroger Posts Better-Than-Expected Earnings, Joins Couchbase, CarMax And Other Big Stocks Moving Higher On Friday 
benzinga.com Crude Oil Moves Higher; Graham Shares Surge After Q4 Results 
benzinga.com Warner Bros. Discovery, Metsera, eToro Group And Other Big Stocks Moving Higher On Monday 
benzinga.com Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? Top performers last week: PONY, HIMS, ODD, MTSR, CGON, KNSA, KC, FTDR, ATI, PRDO, and IRTC. Have you invested in them?
benzinga.com Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday - benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session